Browsing by Author "Capdevila Castillon, Jaume"
Now showing items 1-20 of 40
-
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
Rao, S.; Anandappa, G.; Dahan, L.; Evesque, L.; Kim, S.; Capdevila Castillon, Jaume (Elsevier, 2022-08) -
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Capdevila Castillon, Jaume (Mary Ann Liebert, 2022-05) -
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report
Mirallas Viñas, Oriol; Gomez-Puerto, Diego; Riveiro Barciela, Maria del Mar; Merino Casabiel, Xavier; Auger Acosta, Cristina; García Burillo, Amparo; Molero Richard, Francesc Xavier; Salcedo Allende, Maria Teresa; Capdevila Castillon, Jaume; Landolfi, Stefania; Saoudi Gonzalez, Nadia; Blanco Cuso, Laia (Baishideng Publishing Group, 2021-05-27) -
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
Mirallas Viñas, Oriol; Filippi Arriaga, Maria Francesca Eugenia; Hernández Hernández, Irene; Aubanell, Anton; Chaachou, Anas; Garcia-Alvarez, Alejandro; Hernando Cubero, Jorge; Martinez Saez, Elena Antima; Biagetti Biagetti, Betina; Capdevila Castillon, Jaume (Frontiers Media, 2021-11-11) -
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Macarulla Mercadé, Teresa; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Viaplana Donato, Cristina; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Capdevila Castillon, Jaume; Landolfi, Stefania; Ruiz Pace, Fiorella; Ortiz Velez, Carolina; Dienstmann, Rodrigo (Wiley, 2017-06-15) -
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Castellano, Daniel; Apolo, Andrea; Porta, Camillo; Viteri, Santiago; Rodriguez-Antona, Cristina; Capdevila Castillon, Jaume (SAGE Publications, 2022) -
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial
Brose, Marcia S; Robinson, Bruce G.; Sherman, Steven; Jarząb, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Capdevila Castillon, Jaume (Wiley, 2022-12-15) -
Cabozantinib for the treatment of solid tumors: a systematic review
Maroto, P.; Apolo, Andrea B.; Viteri Ramirez, Santiago; Martin, Lidia; Castellano, D.; Capdevila Castillon, Jaume; Porta, Camillo; Rodriguez-Antona, Cristina (SAGE Publications, 2022-07-13) -
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies
Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Niccoli, Patricia; Capdevila Castillon, Jaume; Curigliano, Giuseppe (Wiley, 2022-09-01) -
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
Trilla-Fuertes, Lucía; Ghanem, Ismael; Maurel, Joan; G-Pastrián, Laura; Mendiola, Marta; Peña, Cristina; Capdevila Castillon, Jaume (Elsevier, 2020-07-01) -
Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe
ELISEI, ROSSELLA; Grande, Enrique; Kreissl, Michael Christoph; Leboulleux, Sophie; Puri, Tarun; Fasnacht, Nicolas; Capdevila Castillon, Jaume (Frontiers Media, 2023-05-03) -
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
Trilla‑Fuertes, Lucía; Gámez‑Pozo, Angelo; Maurel, Joan; Garcia‑Carbonero, Rocio; G‑Pastrián, Laura; Capdevila Castillon, Jaume (Nature Research, 2021-04-01) -
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
Ramage, John; Friend, Elizabeth; Randell, Jordan; King, Barbara; Fernández-Ortega, P.; Mcnamara, Mairéad; Capdevila Castillon, Jaume (Wiley, 2022-04) -
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Hernando Cubero, Jorge; Teule, Alex; Lopez, C.; Garcia-Carbonero, Rocio; Benavent, Marta; Landolfi, Stefania; Capdevila Castillon, Jaume; Nuciforo, Paolo (Nature Portfolio, 2023-05-23) -
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
Pavel, Marianne E.; Ćwikła, Jarosław B.; Lombard-Bohas, Catherine; Borbath, Ivan; Shah, Tahir; Pape, Ulrich F.; Capdevila Castillon, Jaume (Elsevier, 2021-11) -
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Algazi, Alain; Longo, Federico; Miller, Wilson; Bing, Jerry Tan Chun; OH, DO-YOUN; Capdevila Castillon, Jaume (Wiley, 2023-04-15) -
Expert design thinking workshops to analyze users’ perceived applicability of NUTRI-ONCOCARE algorithm to prevent and treat malnutrition in cancer patients under routine clinical practice conditions in Spain: the ALLIANCE study
Moreno, Fernando; Trigo, José; Abilés, Jimena; Sirvent, Mariola; Grande, Enrique; Capdevila Castillon, Jaume (Springer, 2023-09-01) -
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer
Hernando Cubero, Jorge; Alonso, Lola; Fasani, Roberta; Jiménez Flores, José Antonio; Elez Fernandez, Mª Elena; Tabernero Caturla, Josep; Nuciforo, Paolo Giovanni; Capdevila Castillon, Jaume; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Serna, Garazi; Dienstmann, Rodrigo (Elsevier, 2020-10) -
Genetic profile and functional proteomics of anal squamous cell carcinoma: proposal for a molecular classification
Trilla-Fuertes, Lucía; Ghanem, Ismael; Gámez‑Pozo, Angelo; Maurel, Joan; G-Pastrián, Laura; Mendiola, Marta; Capdevila Castillon, Jaume (American Society for Biochemistry and Molecular Biology, 2020-04)